267 related articles for article (PubMed ID: 16166432)
41. Detection of colorectal cancer using MALDI-TOF serum protein profiling.
de Noo ME; Mertens BJ; Ozalp A; Bladergroen MR; van der Werff MP; van de Velde CJ; Deelder AM; Tollenaar RA
Eur J Cancer; 2006 May; 42(8):1068-76. PubMed ID: 16603345
[TBL] [Abstract][Full Text] [Related]
42. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
[TBL] [Abstract][Full Text] [Related]
43. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
[TBL] [Abstract][Full Text] [Related]
44. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.
Gordon SG; Cross BA
Cancer Res; 1990 Oct; 50(19):6229-34. PubMed ID: 2169340
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic markers for early detection of ovarian cancer.
Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
[TBL] [Abstract][Full Text] [Related]
46. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
47. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
[TBL] [Abstract][Full Text] [Related]
48. Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma.
Sartini D; Muzzonigro G; Milanese G; Pierella F; Rossi V; Emanuelli M
J Urol; 2006 Nov; 176(5):2248-54. PubMed ID: 17070307
[TBL] [Abstract][Full Text] [Related]
49. Profiling markers of prognosis in colorectal cancer.
Lyall MS; Dundas SR; Curran S; Murray GI
Clin Cancer Res; 2006 Feb; 12(4):1184-91. PubMed ID: 16489072
[TBL] [Abstract][Full Text] [Related]
50. Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels.
Ikuta Y; Nakatsura T; Kageshita T; Fukushima S; Ito S; Wakamatsu K; Baba H; Nishimura Y
Clin Cancer Res; 2005 Nov; 11(22):8079-88. PubMed ID: 16299239
[TBL] [Abstract][Full Text] [Related]
51. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer.
Japink D; Leers MP; Sosef MN; Nap M
Anticancer Res; 2009 Aug; 29(8):3245-51. PubMed ID: 19661342
[TBL] [Abstract][Full Text] [Related]
52. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
[TBL] [Abstract][Full Text] [Related]
53. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
Zhao Z; Xiao Y; Elson P; Tan H; Plummer SJ; Berk M; Aung PP; Lavery IC; Achkar JP; Li L; Casey G; Xu Y
J Clin Oncol; 2007 Jul; 25(19):2696-701. PubMed ID: 17602074
[TBL] [Abstract][Full Text] [Related]
54. Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.
Herbst A; Rahmig K; Stieber P; Philipp A; Jung A; Ofner A; Crispin A; Neumann J; Lamerz R; Kolligs FT
Am J Gastroenterol; 2011 Jun; 106(6):1110-8. PubMed ID: 21326223
[TBL] [Abstract][Full Text] [Related]
55. [Alcohol dehydrogenase and aldehyde dehydrogenase as tumour markers and factors intensifying carcinogenesis in colorectal cancer].
Jelski W; Orywal K; Kedra B; Szmitkowski M
Pol Merkur Lekarski; 2008 Jun; 24(144):506-10. PubMed ID: 18702331
[TBL] [Abstract][Full Text] [Related]
56. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
57. Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer.
Petrova DT; Asif AR; Armstrong VW; Dimova I; Toshev S; Yaramov N; Oellerich M; Toncheva D
Clin Biochem; 2008 Oct; 41(14-15):1224-36. PubMed ID: 18710659
[TBL] [Abstract][Full Text] [Related]
58. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
[TBL] [Abstract][Full Text] [Related]
59. Occurrence of hematogenous metastasis and serum levels of thymidine phosphorylase in colorectal cancer.
Haraguchi M; Komuta K; Akashi A; Furui J; Kanematsu T
Oncol Rep; 2003; 10(5):1207-12. PubMed ID: 12883682
[TBL] [Abstract][Full Text] [Related]
60. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.
Chen Y; Zhang H; Xu A; Li N; Liu J; Liu C; Lv D; Wu S; Huang L; Yang S; He D; Xiao X
Lung Cancer; 2006 Oct; 54(1):95-102. PubMed ID: 16890323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
